A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects with Ocular Hypertension or Open-Angle Glaucoma
A Phase 2 Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects with Ocular Hypertension (OH) or Open-Angle Glaucoma (OAG)
The purpose of this study is to evaluate the efficacy, safety and duration of the L-PPDS (latanoprost punctal plug delivery system) at different dose levels.
For more information, visit ClinicalTrials.gov.
Contact Information
QLT Medical Information
1-877-764-3131
medaff@qltinc.com
|
